Ocular Manifestations of Multiple Sclerosis: A Population-Based Study
Jessica A. Kraker,Sarah Chaoying Xu,Eoin P. Flanagan,Robert Foster,Feng Wang,John J. Chen
DOI: https://doi.org/10.1097/wno.0000000000002116
2024-03-08
Journal of Neuro-Ophthalmology
Abstract:Background: To evaluate the population-based frequency and severity of multiple sclerosis (MS)-related ocular diseases. Methods: Retrospective, population-based study examining patients with MS between January 1, 1998 and December 31, 2011. Patients were identified using the Rochester Epidemiology Project, which is a record-linkage system of medical records for all patient–physician encounters among Olmsted County, Minnesota residents. Diagnosis of MS was confirmed based on neuroimaging, cerebrospinal fluid studies, and serum studies for each patient according to the 2017 McDonald criteria. Patient data were obtained using the medical records and followed through April 1, 2018. Results: Of the 116 patients with MS, 66% were female and the median age of onset was 36 years (interquartile range 27.5–43.5 years). About half (61/116, 53%) had MS-related neuro-ophthalmic manifestations during their disease course, and about one-fourth (33/116, 28%) had visual symptoms as their presenting symptom of MS, most commonly as optic neuritis (26/116, 22%). Optic neuritis was the leading MS-related ocular condition (37%), followed by internuclear ophthalmoplegia (16%) and nystagmus (13%). Optic neuritis was mostly unilateral (40/43, 93%), with 16% (6/43) having a visual acuity of 20/200 or worse at nadir but ultimately 95% (35/37) improving to a visual acuity of 20/40 or better. Conclusions: This study provides the population-based frequency of MS-related ocular disease, which demonstrates a high frequency of ocular manifestations in MS both at disease onset and during the disease course, emphasizing the utility of neuro-ophthalmologists, or collaboration between neurologists and ophthalmologists, in the care of patients with MS.
ophthalmology,clinical neurology